SEC Form D · filed December 13, 2017
Kv1.3 Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Daniel Raymond · Seattle, WADirectorRobert Hedequist · Seattle, WADirectorShawn Iadonato · Seattle, WADirectorGavin Jancke · SEATTLE, WADirectorCraig Philips · Seattle, WAExecLucien Fouke · Seattle, WADirectorLord Farmer · LONDON, United KingdomDirectorRon W. Pauli · San Francisco, CADirectorPaul G. Coughlan · London, United KingdomExecRichard J. Nesbit · San Francisco, CADirectorLlew J. Keltner · San Francisco, CADirectorDaniel J. Tasse · San Francisco, CADirectorJoshua W. Kriesel · San Francisco, CADirectorStephen F. Mahedy · Beltsville, MDExecMichael Hanrahan · Downers Grove, ILDirectorRichard W. Pascoe · Celebration, FLDirectorJoseph B. Saluri · Celebration, FLDirectorSven L. Guenther · Celebration, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗